Kalfoton injection solution 100ml
DESCRIPTION
Kalfoton is a veterinary injection drug for the treatment of mineral metabolism disorders in animals. Dosage form: injection solution. In appearance, the drug is a pale yellow transparent solution.
ADVANTAGES
Regulates calcium, phosphorus and energy metabolism
Eliminates signs of tetany
Essential drug for postpartum paresis and paralysis
Effective in the treatment of toxicosis and allergies
Import substitution drug - favorable price
COMPOSITION
1 ml of Kalfoton contains as active ingredients: calcium gluconate - 0.33 g, calcium glycerophosphate - 0.082 g, magnesium chloride - 0.042 g and excipients: boric acid, anhydrous sodium citrate (in the amount required to correct pH 3.5 - 4.5), water for injection - up to 1 ml.
PHARMACOLOGICAL PROPERTIES
Kalfoton belongs to a group of medicines containing calcium, phosphorus, magnesium.
The mechanism of action of a drug is determined by the effect of its constituent components. Calcium is involved in the formation of bone tissue (prevents the risk of rickets and osteodystrophy), in blood coagulation, in the regulation of nerve conduction and muscle contractions, in maintaining stable cardiac activity. It has a tonic, antitoxic effect. Phosphorus is a constituent of bone tissue, nucleoproteins and phospholipids. He takes part in all the processes of assimilation in the body of the animal, has a positive effect on the metabolism in the tissues of the body. Magnesium is involved in the metabolism of phosphorus and carbohydrates as a coenzyme. When administered parenterally, it blocks neuromuscular transmission and prevents the development of seizures. The active ingredients are in a physiological ratio, well and quickly absorbed after parenteral administration. According to the degree of impact on the body, Kalfoton belongs to low-hazard substances (hazard class 4 according to GOST 12.1.007).
DOSAGE AND APPLICATION
Kalfoton is prescribed to animals as part of complex treatment and prophylaxis for: tetany (during pregnancy, lactation, during transportation, grazing, etc.); paresis, paralysis of various etiologies (including postpartum); rickets, osteodystrophy, osteomalacia; allergies, toxicosis; disorders of mineral metabolism (metabolic disorders of calcium, phosphorus, magnesium); fractures.
Kalfoton is administered to animals parenterally intravenously, intramuscularly or subcutaneously at a dose of 2 ml per 10 kg of animal weight: cattle, horses - 20 ml per 100 kg of live weight of the animal; young cattle - 10 ml per 50 kg of live weight of the animal; pigs - 20 ml per 100 kg of live weight of the animal; replacement young animals - 10 ml per 50 kg of live weight of the animal; weaning piglets - 2 ml per 10 kg of live weight of the animal; sheep and goats - 20 ml per 100 kg of live weight of the animal; young animals - 2 ml per 10 kg of live weight of the animal; dogs - 2 ml per 10 kg of animal live weight; cats - 0.5 ml per 5 kg of live weight of the animal.
Re-use of the drug is allowed after 24 hours in the same doses. For the prevention of metabolic disorders of calcium, phosphorus and magnesium during pregnancy, lactation, as well as rickets of young animals, Kalfoton is used once in the recommended doses. In cattle, Kalfoton is injected subcutaneously into the same place no more than 50 ml, intramuscularly - no more than 25 ml. Pigs, sheep and goats intramuscularly in the same place - no more than 15 ml of the drug. The drug is administered intravenously slowly and evenly.
SPECIAL INSTRUCTIONS
Symptoms arising from an overdose of the drug have not been established in animals.
The peculiarities of the action of the drug during the first application or upon its withdrawal were not revealed.
In recommended doses, it does not have teratogenic and embryotoxic effects. Contraindications and features of use during lactation have not been established.
The drug is intended for single use.
Kalfoton should not be used simultaneously with digitalis preparations, vitamin D and its analogs.
The slaughter of animals for meat and the use of meat products and milk for food purposes during and after the use of Kalfoton is allowed without restrictions.
CONTRAINDICATIONS
Kalfoton is contraindicated in hypercalcemia, acidosis, severe renal dysfunction, atrial fibrillation, hypersensitivity to the components of the drug.
SIDE EFFECTS
When using Kalfoton according to this instruction, side effects and complications in animals, as a rule, are not observed. In the event of allergic reactions, the use of the drug is stopped and antihistamines are prescribed and, if necessary, symptomatic treatment.
SHELF LIFE AND STORAGE
The shelf life of the drug, subject to storage conditions, is 3 years from the date of production, after the first opening of the bottle - no more than 28 days. It is prohibited to use the medicinal product after the expiration date.
Store the drug in the manufacturer's closed packaging in a dry place protected from direct sunlight, separately from food and feed at a temperature of 5 to 25 В° C. After opening the bottle - at a temperature of 5 to 8 В° C.
PACKAGING
The drug is produced in the form of a sterile solution of 100 ml in glass vials of appropriate capacity, hermetically sealed with rubber stoppers, reinforced with aluminum caps. Each consumer package of the drug is supplied with instructions for use.
Specifications
KolVUP
48
Manufacturer
Askont +
Temperature regime
from +5 to +25
Teaser
for the treatment of disorders of mineral metabolism in animals